Delisting risk
MetaVia (MTVA)
Clinical developer of obesity and MASH therapies.
$1.83
Pre-market−0.01 (−0.56%)
At close$1.84(+6.98%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions12 holders · as of Mar 31, 2026 | 1.30% | 67.0K shares | |
| Insiders8 holders · as of Jun 8, 2026 | 3.77% | 194.8K shares | |
| Strategic holders1 holder · as of May 20, 2025 | 17.60% | 908.7K shares | |
| Otherremainder | 77.33% | 3.99M shares |
5.16M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (5.16M in the company's Sep 3, 2026 report, 2.20M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
12 holders · 67.0K shares · 6 new positions · 8 increased · 1 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 33.6K | 0.65% | +33.6Knew | May 15, 2026 |
| Jane Street Group, LLC | 10.9K | 0.21% | +10.9Knew | May 12, 2026 |
| Aries Wealth Management | 10.0K | 0.19% | +10.0Knew | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 6.9K | 0.13% | +6.9Knew | May 8, 2026 |
| Tower Research Capital LLC (TRC) | 2.6K | 0.05% | +2.4K | May 15, 2026 |
| Vanguard Capital Management LLC | 2.2K | 0.04% | +2.2Knew | May 15, 2026 |
| BlackRock, Inc. | 479 | 0.01% | 0 | May 13, 2026 |
| Sbi Securities Co., Ltd. | 205 | 0.00% | +64 | Apr 28, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 9.99% | 508.6K | 13G | May 15, 2026 ↗ |
| Armistice Capital, LLC | 9.99% | 13G | Feb 14, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.